imidacloprid, moxidectin - search results

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advocate for cats over 4kg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advocate for kittens and small cats up to 4kg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advocate for dogs over 25kg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advocate for dogs 10-25 kg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advocate for dogs 4-10 kg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advocate for puppies and small dogs up to 4 kg

United States - English - NLM (National Library of Medicine)

advantage multi for dogs- imidacloprid moxidectin solution

bayer healthcare llc animal health division - imidacloprid (unii: 3bn7m937v8) (imidacloprid - unii:3bn7m937v8), moxidectin (unii: ngu5h31yo9) (moxidectin - unii:ngu5h31yo9) - imidacloprid 100 mg in 1 ml - advantage multi for dogs is indicated for the prevention of heartworm disease caused by dirofilaria immitis and the treatment of dirofilaria immitis circulating microfilariae in heartworm-positive dogs. advantage multi for dogs kills adult fleas and is indicated for the treatment of flea infestations (ctenocephalides felis ). advantage multi for dogs is indicated for the treatment and control of sarcoptic mange caused by sarcoptes scabiei var. canis. advantage multi for dogs is also indicated for the treatment and control of the following intestinal parasites: intestinal parasite intestinal stage adult immature adult fourth stage larvae hookworm species ancylostoma caninum x x x uncinaria stenocephala x x x roundworm species toxocara canis x x toxascaris leonina x whipworm trichuris vulpis x do not administer this product orally. (see warnings.) do not use this product (containing 2.5% moxidectin) on cats.

European Union - English - EMA (European Medicines Agency)

imoxat

chanelle pharmaceuticals manufacturing ltd - imidacloprid, moxidectin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme).the veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (fad). for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis). for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis).the veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (fad).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

moxidectin and imidacloprid spot on for puppies and small dogs up to 4 kg

redcap solutions pty ltd - moxidectin; imidacloprid - topical solution/suspension - moxidectin anthelmintic active 25.0 g/l; imidacloprid guanidine active 100.0 g/l - parasiticides

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

moxidectin and imidacloprid spot on for cats over 4 kg

redcap solutions pty ltd - moxidectin; imidacloprid - topical solution/suspension - moxidectin anthelmintic active 10.0 g/l; imidacloprid guanidine active 100.0 g/l - parasiticides